We are live on ! Find out more
RPTP

Raptor Pharmaceutical
RPTP

Delisted

RPTP was delisted on the 24th of October, 2016.

100 hedge funds and large institutions have $674M invested in Raptor Pharmaceutical in 2015 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 49 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,113% more capital inflows, than outflows

Capital inflows: $133M | Capital outflows: $11M

500% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 5

390% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 10

33% more funds holding

Funds holding: 75 → 100 (+25)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

20% less call options, than puts

Call options by funds: $57.2M | Put options by funds: $71.8M

Holders
100
Holders Change
+25
Holders Change %
+33.33%
% of All Funds
2.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
30
Increased
49
Reduced
10
Closed
5
Calls
$57.2​M
Puts
$71.8​M
Net Calls
-⁠$14.6​M
Net Calls Change
+$8.26​M

RPTP Hedge Fund Activity: Q2 2015 in Review

100 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Raptor Pharmaceutical (RPTP) for Q2 2015, worth a combined $674M — up 90% from $355M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new RPTP positions and 5 closed out — a net gain of 25 holders — while 49 added to existing stakes and 10 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $16.3M. The largest seller was Jane Street, cutting an estimated $2.9M.

  • 100 institutional investors held Raptor Pharmaceutical (RPTP) as of Q2 2015, up from 75 in Q1 2015.
  • Funds reported $674M of Raptor Pharmaceutical stock for Q2 2015, up 90% quarter-over-quarter.
  • 30 funds opened new Raptor Pharmaceutical positions in Q2 2015 and 5 closed out, a net change of +25 holders.
  • The largest Raptor Pharmaceutical buyer in Q2 2015 was D.E. Shaw & Co, an estimated $16.3M added.
  • The largest Raptor Pharmaceutical seller in Q2 2015 was Jane Street, an estimated $2.9M sold.

Based on aggregated 13F filings for Q2 2015.